Business Wire

ARJO-SOLUTIONS

7.11.2016 16:02:28 CET | Business Wire | Press release

Share
Arjo Solutions Launches SAFE, the First Smartphone Application That Lets Consumers Verify the Authenticity of a Product and Fight against Counterfeiting.

Estimated at $1770 Billion dollars by the International Chamber of Commerce, the counterfeiting of products and the illicit trade are global issues that cause a lot of economic, health and social damage.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161107005118/en/

Developed by Arjo Solutions, Signoptic® technology, based on the fingerprint of the material, already protects many major brands in order to fight against counterfeiting and parallel markets. By generating a unique digital identity from the material of the product, Signoptic® lets you verify its authenticity and ensure its traceability.

To make the technology of material biometrics accessible to consumers, Arjo Solutions has developed SAFE, an innovative application enabling the use of Signoptic® technology on a simple smartphone, without any accessory, or specific reader.

With SAFE, brands now have a powerful and easy-to-use solution for their customers. This means verifying the authenticity of their products, in any place and at any time will strengthen consumers' confidence in their brand.

SAFE also incorporates a marketing platform enabling brands to use this new tool to propose new services to their customers: product information, promotional operations, traceability, etc.

Arjo Solutions will present SAFE at the Salon All4Pack on November 14th to 17th, 2016 in Paris through several demonstrations at booth 55, Hall 7, Aisle M. Contact us to make an appointment and receive your free invitation.

About Arjo Solutions

Arjo Solutions, an expert in security for over 15 years, designs and provides physical and digital solutions for identification, authentication and traceability of products in order to enable its customers to combat fraud, counterfeiting and parallel markets. Arjo Solutions is a company of the Impala Group.

About Signoptic ® technology

Signoptic ® is a patented technology based on a vision system that enables the conversion of a product's texture into a unique digital signature thanks to a proprietary algorithm. Because this signature is generated from non-reproducible elements of the product itself, Signoptic ® enables both the identification and authentication of the product.

Contact:

Arjo Solutions
Olivier ROUAULT, +339,724,106 55
Mobile: +336,729,048 68
Marketing Manager
olivier.rouault@arjo-solutions.com
www.arjo-solutions.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

NetApp and Elastio Announce Partnership to Deliver Defense-in-Depth Ransomware Resilience24.3.2026 13:00:00 CET | Press release

Robust cyber resilience requires both perimeter defenses and built-in security at the storage layer NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, and Elastio are helping enterprises enhance their cyber resilience with a layered defense that extends from production storage into recovery data. Security teams must be ready to address threats at every layer of their technology stack, including ransomware that moved quietly through production before it was caught that now lives inside snapshots and backups. Advanced ransomware is engineered to evade prevention tools, moving quietly through production, staying below detection thresholds, reaching backup data before any alert is triggered. "As we migrated our infrastructure, ensuring we had the right level of backup security and assurance was non-negotiable,” Marc Crudgington, VP IT Infrastructure and CISO, Crane WW Logistics. “Elastio provided continuous inspection of our backups from day one - giving us confidence in

NetApp and Commvault Advance Cyber Resilience with Strategic Alliance24.3.2026 13:00:00 CET | Press release

Joint unified cyber resilience solution delivers data security and rapid recovery across hybrid environments NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, and Commvault (NASDAQ: CVLT), a leader in unified resilience at enterprise scale, today announced a strategic alliance to deliver a powerful, integrated solution for enterprise data protection and cyber resilience. The unified solution enables resilience, security, and rapid recovery for customers across on-premises and cloud environments, giving organizations confidence that their data is always available, immutable, and recoverable. “This alliance reinforces NetApp and Commvault’s leadership in the rapidly evolving cyber resilience and data protection market,” said Dallas Olson, Chief Commercial Officer at NetApp. “Together we’re helping customers make their infrastructure intelligent and secure so they have the confidence that their data is always available, protected, and recoverable—no matter where it live

SBC Medical Announces Next-Generation Wellness Strategy “SBC Wellness 2.0”24.3.2026 13:00:00 CET | Press release

Pioneering the “Performance Medicine” category for full-scale entry into the longevity market — targeting a global market projected to reach $2 trillion by 2035 SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced “SBC Wellness 2.0,” a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323000188/en/ SBC Medical Announces Next-Generation Wellness Strategy “SBC Wellness 2.0” The initiative positions SBC Medical to participate in the fast-growing longevity market, which is projected to reach approximately $800 billion in 2025* and expand to approximately $2 trillion by 2035, with a compound annual growth rate exceeding 10% from 2026 to 2035. Th

Andy Walsky of ExaGrid Honored as A 2026 CRN EMEA Channel Leader24.3.2026 13:00:00 CET | Press release

ExaGrid®, the leader in Tiered Backup Storage, today announced that CRN UK—a brand of The Channel Company—has selected Andy Walsky, VP of EMEA & APAC Sales, for inclusion on the prestigious 2026 CRN® Channel Leaders EMEA list. This annual recognition celebrates IT vendor and distribution executives who are shaping channel strategy and driving innovation and partnership across the industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260324173870/en/ ExaGrid works with resellers and distributors worldwide. The ExaGrid channel programs are designed to be easy for partners, with support from the ExaGrid sales team and without milestone commitments. ExaGrid is known for having a Tiered Backup Storage system that “just works,” is not oversold or undersized, and provides its customers with the best customer support in the industry with an assigned level 2 technical support engineer, ensuring that partners’ customers are well ta

Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights24.3.2026 12:30:00 CET | Press release

COMP360 is the first classic psychedelic1 to consistently achieve a highly statistically significant result and clinically meaningful effect in treatment resistant depression (TRD), with a generally well-tolerated and safe profileAcross three large trials in TRD, including two positive Phase 3 studies, COMP360’s differentiated profile is redefining rapidity and durability for TRD patients and demonstrating a consistent level of clinical effect that has never been achieved beforeCompass will meet with the FDA to confirm alignment on a rolling submission and review, and expects to complete the NDA submission in Q4Compass is rapidly advancing commercial readiness plans and expects COMP360 will fit seamlessly across diverse healthcare settings at launchPhase 2b/3 trial in PTSD initiating, following FDA acceptance of IND applicationSuccessful $150 million financing in February and exercise of $200 million in warrants extends cash runway into 2028 Compass Pathways plc (Nasdaq: CMPS), a biote

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye